Solvay and Anthea join forces for catechol derivatives
Solvay, a producer of flavour and fragrance ingredients, and Anthea, a manufacturer of specialty chemicals in India, have recently concluded an agreement to establish a joint venture named Catàsynth Speciality Chemicals, dedicated to the production of catechol derivatives.
Through this joint venture, the two companies will work together to meet customers’ needs for additional, reliable supply for a range of products including methylenedioxybenzene, heliotropin (piperonal) and helional, which are key ingredients for applications in the flavour industry among others.
Catàsynth is currently completing a brand-new, world-class manufacturing facility in Mangalore, India which will be fully operational in Q1 2020.
“We have been producing synthetic heliotropin for the flavours and fragrances market since 2010 in Crown Chemicals, based on our patented manufacturing processes. Through this partnership with Solvay, we are significantly expanding our production capacities of methylenedioxybenzene and heliotropin, and also enlarging our product range to address other derivatives for the Agrochemical and Pharma market,” said Dr Vincent Paul, founder and chairman of the Anthea Group.
“This partnership is fully aligned with our strategy to reinforce downstream integration. Solvay is committed to continue enlarging its product offer for the Flavour, Fragrance, Agrochemical & Pharma markets whilst ensuring excellent quality and security of supply,” added Peter Browning, president of Solvay Aroma Performance GBU.
The closing of the deal is expected to occur early Q1 2020.